NCT04913753

Brief Summary

The value of cytobacteriological examination of urine (CBEU) before double J catheter removal has not been demonstrated. The aim of this study is to define the interest of this CBEU.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 4, 2021

Completed
6 days until next milestone

Study Start

First participant enrolled

June 10, 2021

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 3, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 3, 2025

Completed
Last Updated

December 12, 2025

Status Verified

December 1, 2025

Enrollment Period

4.5 years

First QC Date

May 19, 2021

Last Update Submit

December 4, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of infection

    Incidence over a month period of post-ablation symptomatic urinary infection defined by the presence of symptoms validated by an adjudication committee (urine burning, fever, urgencies… associated to a significant bacteriuria) - each patient will be contacted by phone at month 1 (± 5 days) and will be asked to contact us in case of suspicion of urinary infection.

    1 month post double J removal

Secondary Outcomes (7)

  • Incidence of bacteriuria measured by CBEU

    1 month post double J removal

  • Description of the resistance type of pre-operative distribution of bacteriuria by CBEU

    10 days to 4 days before double J removal

  • Description of the pre-operative distribution of bacteriuria by CBEU

    10 days to 4 days before double J removal

  • Description of the resistance type of post operative distribution of bacteriuria by CBEU

    1 month after double J removal

  • Description of the post operative distribution of bacteriuria by CBEU

    1 month after double J removal

  • +2 more secondary outcomes

Study Arms (2)

No systematic CBEU

EXPERIMENTAL

Patients will not have bacterial culture performed before double J removal.

Procedure: No CBEU

Systematic CBEU

ACTIVE COMPARATOR

Patients will have a systematic urine culture performed before double J removal.

Procedure: CBEU

Interventions

CBEUPROCEDURE

Patients in the control group will have bacterial culture and double J removal will be performed as usual. .

Systematic CBEU
No CBEUPROCEDURE

Patients in the experimental group will have bacterial culture and double J removal will be performed as usual. .

No systematic CBEU

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant ≥ 18 years of age
  • Scheduled to have a double J catheter ablation
  • Participants covered by or entitled to social security
  • Written informed consent obtained from the participant
  • Ability for participant to comply with the requirements of the study

You may not qualify if:

  • Patients already receiving antibiotics other than urological reasons and transplanted patients
  • Study interventions contraindications
  • Pregnancy, breastfeeding
  • Patient under tutorship or curators
  • Deprivation of liberty

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BRUYERE

Tours, 37044, France

Location

MeSH Terms

Conditions

Urinary Tract Infections

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2021

First Posted

June 4, 2021

Study Start

June 10, 2021

Primary Completion

December 3, 2025

Study Completion

December 3, 2025

Last Updated

December 12, 2025

Record last verified: 2025-12

Locations